Intco Medical Technology Co., Ltd.

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CNE100003456
CNY
43.30
0.08 (0.19%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidate Annual Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
9,457.77
6,851.43
6,558.42
16,196.02
13,780.67
2,064.49
1,873.73
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
9,457.77
6,851.43
6,558.42
16,196.02
13,780.67
2,064.49
1,873.73
Raw Material Cost
7,503.82
6,144.38
5,886.30
6,335.82
4,316.95
1,576.48
1,434.43
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Employee Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
322.22
135.67
31.92
21.11
24.43
30.36
15.78
Selling and Distribution Expenses
636.06
611.25
495.34
933.05
563.96
206.15
192.22
Other Expenses
4.80
12.58
20.05
32.43
26.12
3.43
4.42
Total Expenditure (Excl Depreciation)
8,510.06
7,017.07
6,614.07
7,614.30
5,166.54
1,847.29
1,686.67
Operating Profit (PBDIT) excl Other Income
947.6999999999999
-165.6
-55.599999999999994
8581.699999999999
8614.1
217.2
187.10000000000002
Other Income
798.44
573.58
776.08
61.02
-245.24
14.38
39.61
Operating Profit (PBDIT)
2,549.84
1,126.13
1,331.72
9,005.30
8,507.55
323.63
305.42
Interest
322.22
135.67
31.92
21.11
24.43
30.36
15.78
Exceptional Items
245.84
175.89
35.69
32.81
3.61
2.50
-3.18
Gross Profit (PBDT)
1,953.94
707.05
672.12
9,860.20
9,463.73
488.01
439.30
Depreciation
864.55
723.54
631.08
368.31
140.09
92.49
79.85
Profit Before Tax
1,608.92
442.82
704.41
8,648.69
8,346.64
203.27
206.61
Tax
117.23
54.75
65.07
1,185.22
1,342.13
25.01
27.28
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
1,465.48
383.00
629.07
7,430.08
7,007.05
178.32
179.34
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
1,465.48
383.00
629.07
7,430.08
7,007.05
178.32
179.34
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
26.21
5.07
10.27
33.40
-2.54
-0.05
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
1,491.69
388.06
639.34
7,463.47
7,004.51
178.27
179.34
Equity Capital
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
17,404.08
16,028.59
15,806.33
15,871.20
9,343.84
1,436.21
1,273.08
Earnings per share (EPS)
2.26
0.58
0.95
11.0
11.31
0.33
0.34
Diluted Earnings per share
2.26
0.58
0.95
11.0
11.31
0.33
0.34
Operating Profit Margin (Excl OI)
9.38%
-2.5%
-1.15%
52.95%
62.5%
10.5%
9.92%
Gross Profit Margin
26.15%
17.02%
20.36%
55.67%
61.58%
14.33%
15.29%
PAT Margin
15.49%
5.59%
9.59%
45.88%
50.85%
8.64%
9.57%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Annual Analysis Highlights
stock-summary

Net Sales

YoY Growth in year ended Dec 2024 is 38.04% vs 4.47% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in year ended Dec 2024 is 284.36% vs -39.29% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in year ended Dec 2024 is 216.94% vs -0.54% in Dec 2023

stock-summary

Interest

YoY Growth in year ended Dec 2024 is 137.44% vs 325.39% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in year ended Dec 2024 has improved from Dec 2023

Compare Annual Results Of Intco Medical Technology Co., Ltd. With
Markets Mojo
Figures in Million
Consolidate Annual Results
Markets Mojo
Markets Mojo
Change(CNY)
Change(%)
Net Sales
9,457.77
0
9,457.77
Other Operating Income
0.00
0.00
0.00
Total Operating income
9,457.77
0
9,457.77
Raw Material Cost
7,503.82
0
7,503.82
Purchase of Finished goods
0
0
0.00
(Increase) / Decrease In Stocks
0
0
0.00
Employee Cost
0.00
0
0.00
Power Cost
0
0
0.00
Manufacturing Expenses
322.22
0
322.22
Selling and Distribution Expenses
636.06
0
636.06
Other Expenses
4.80
0.00
4.80
Total Expenditure (Excl Depreciation)
8,510.06
0
8,510.06
Operating Profit (PBDIT) excl Other Income
947.71
0.00
947.71
Other Income
798.44
0
798.44
Operating Profit (PBDIT)
2,549.84
0
2,549.84
Interest
322.22
0
322.22
Exceptional Items
245.84
0
245.84
Gross Profit (PBDT)
1,953.94
0
1,953.94
Depreciation
864.55
0
864.55
Profit Before Tax
1,608.92
0
1,608.92
Tax
117.23
0
117.23
Provisions and contingencies
0
0
0.00
Profit After Tax
1,465.48
0
1,465.48
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0
0
0.00
Other Adjustments
0
0
0.00
Net Profit
1,465.48
0
1,465.48
Share in Profit of Associates
0
0
0.00
Minority Interest
26.21
0
26.21
Other related items
0.00
0.00
0.00
Consolidated Net Profit
1,491.69
0
1,491.69
Equity Capital
0
0
0.00
Face Value
1.00
0
0.00
Reserves
17,404.08
0
17,404.08
Earnings per share (EPS)
2.26
0
2.26
Diluted Earnings per share
2.26
0
2.26
Operating Profit Margin (Excl OI)
9.38%
0%
0.00
9.38%
Gross Profit Margin
26.15%
0%
0.00
26.15%
PAT Margin
15.49%
0%
0.00
15.49%
Public Share Holdings (%)
0%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0%
0%
0.00
0.00%
Annual - Net Sales
Net Sales 945.78 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 38.04% vs 4.47% in Dec 2023

Annual - Consolidate Net Profit
Consolidate Net Profit 149.17 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 284.36% vs -39.29% in Dec 2023

Annual - Operating Profit (PBDIT)
Operating Profit (PBDIT) 175.14 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 216.94% vs -0.54% in Dec 2023

Annual - Interest
Interest 32.22 Million
in Dec 2024

Figures in Million
stock-summary

YoY Growth in year ended Dec 2024 is 137.44% vs 325.39% in Dec 2023

Annual - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 9.38%
in Dec 2024

Figures in %
stock-summary

YoY Growth in year ended Dec 2024 has improved from Dec 2023